Global private equity and venture capital news and research

CDH, China Grand Pharma buddy up for Shangai Weicon contact lens buyout

26 Jun 2014

contact lensChinese private equity firm CDH Investments has teamed with China Grand Pharmaceutical & Healthcare to buy a majority stake in contact lens maker Shanghai Weicon Optical.

The $78.7m deal will see the pair pick up just over 71 per cent of the business according to a regulatory filing.

CDH will hold 19 per cent of Shanghai Weicon by parting with $21m, with China Grand Pharma holding the balance of the investment.

The pair have also agreed to invest $15m in the future growth of the company, with $4m of this coming from CDH.

Shanghai Weicon has more than 30 per cent share in the Chinese contact lens market.

Copyright © 2014 AltAssets

AltAssets Mobile App

To access the latest private equity news and stories download the new AltAssets mobile app from the

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015